Susan Hasty, Publisher
Table of Contents . . . December 7th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Neurology - Gene Therapy to Save Neurons Does Not Always Preserve Their Function
Adenovirus-Based Gene Therapy - Transgene Expression Vectors are Safe in Highly Cirrhotic Livers
Cancer Gene Therapy - Agent Demonstrates Tumor Suppression Activity
Cancer Gene Therapy - Strategies Target Type 1 Insulin-Like Growth Factor Receptor
Gene Medicine - Improved Gene Regulation System Announced
Glioma - Reovirus Therapy Successful in Animal Models
Kidney Disease - Adenoviral-Microsphere Complexes Deliver Gene Therapy for Glomerulonephritis
Melanoma - Antisense Drug Reported Active in Malignant Disease
Myocardial Ischemia - Gene Transfer of Growth Factor Promotes Angiogenesis
Ophthalmology - Gene Therapy Retards Photoreceptor Degeneration in Retinitis Pigmentosa Model
Tissue Engineering - Muscle Cells Grown to Repair Heart Damage
Cell-Based Gene Therapy - Patent Issued for Genetic Modification and Use of Key Human Immune System Cell
Drug Development - Oral Antisense Drug Successfully Completes Human Clinical Trials
Head/Neck Cancer - Phase II MG98 Trial Commences
Hemophilia - Avigen Signs Gene Therapy Deal with Bayer
Hemophilia - Collaboration Will Develop Gene Therapeutics
Breast Cancer - Women with Early Stage Disease Sought for Drug Evaluation
Cancer Gene Therapy - Patent Announced for Non-Viral Delivery System of Interleukin-2
Cardiovascular Gene Therapy - One-Year Results from Vessel Growth Factor Trial are Encouraging
Dermatology - In vivo Results of Telomerase Activation Reported
Drug Development - Progress with Targeted, Anticancer, Virus-Based Therapeutics Reported
Drug Development - Protein-Modulating Compounds Could Increase Levels of "Good" Cholesterol
Head and Neck Cancer - Cell Studies May Further Gene Therapy Prospects
Prostate Cancer - Activity Reported for Genasense in Cancer Combination Therapy
Type 2 Diabetes - Muscular Respiratory Uncoupling May Be Protective
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.